Selected research
Industry Growth & Trends
Global Hypnotics and Sedatives Industry Growth and Trends Forecast to 2032
Market perspective
The global Hypnotics and Sedatives market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Hypnotics and Sedatives is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Hypnotics and Sedatives is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Hypnotics and Sedatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Hypnotics and Sedatives include Abbott, Takeda, Sanofi, Novartis, Mylan, Pfizer, Fresenius Kabi, Baxter and Sands Pharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Hypnotics and Sedatives market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Hypnotics and Sedatives market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hypnotics and Sedatives market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hypnotics and Sedatives.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Hypnotics and Sedatives market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Hypnotics and Sedatives Market by Company
Abbott
Takeda
Sanofi
Novartis
Mylan
Pfizer
Fresenius Kabi
Baxter
Sands Pharm
Hospira
Cobalt Laboratories
Hypnotics and Sedatives Segment by Type
Capsule
Solution
Suppository
Injectable
Hypnotics and Sedatives Segment by Application
Hospital
Clinic
Hypnotics and Sedatives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hypnotics and Sedatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hypnotics and Sedatives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hypnotics and Sedatives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hypnotics and Sedatives manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Hypnotics and Sedatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsule
- Solution
- Suppository
- Injectable
Applications
- Hospital
- Clinic
Companies covered
- Abbott
- Takeda
- Sanofi
- Novartis
- Mylan
- Pfizer
- Fresenius Kabi
- Baxter
- Sands Pharm
- Hospira
- Cobalt Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Hypnotics and Sedatives Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Hypnotics and Sedatives Sales Estimates and Forecasts (2021-2032)
- 1.3 Hypnotics and Sedatives Market by Type
- 1.3.1 Capsule
- 1.3.2 Solution
- 1.3.3 Suppository
- 1.3.4 Injectable
- 1.4 Global Hypnotics and Sedatives Market Size by Type
- 1.4.1 Global Hypnotics and Sedatives Market Size Overview by Type (2021-2032)
- 1.4.2 Global Hypnotics and Sedatives Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Hypnotics and Sedatives Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Hypnotics and Sedatives Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Hypnotics and Sedatives Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Hypnotics and Sedatives Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Hypnotics and Sedatives Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Hypnotics and Sedatives Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Hypnotics and Sedatives Industry Trends
- 2.2 Hypnotics and Sedatives Industry Drivers
- 2.3 Hypnotics and Sedatives Industry Opportunities and Challenges
- 2.4 Hypnotics and Sedatives Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Hypnotics and Sedatives Revenue (2021-2026)
- 3.2 Global Top Players by Hypnotics and Sedatives Sales (2021-2026)
- 3.3 Global Top Players by Hypnotics and Sedatives Price (2021-2026)
- 3.4 Global Hypnotics and Sedatives Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Hypnotics and Sedatives Major Company Production Sites & Headquarters
- 3.6 Global Hypnotics and Sedatives Company, Product Type & Application
- 3.7 Global Hypnotics and Sedatives Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Hypnotics and Sedatives Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Hypnotics and Sedatives Players Market Share by Revenue in 2025
- 3.8.3 2025 Hypnotics and Sedatives Tier 1, Tier 2, and Tier 3
4 Hypnotics and Sedatives Regional Status and Outlook
- 4.1 Global Hypnotics and Sedatives Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Hypnotics and Sedatives Historic Market Size by Region
- 4.2.1 Global Hypnotics and Sedatives Sales in Volume by Region (2021-2026)
- 4.2.2 Global Hypnotics and Sedatives Sales in Value by Region (2021-2026)
- 4.2.3 Global Hypnotics and Sedatives Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Hypnotics and Sedatives Forecasted Market Size by Region
- 4.3.1 Global Hypnotics and Sedatives Sales in Volume by Region (2027-2032)
- 4.3.2 Global Hypnotics and Sedatives Sales in Value by Region (2027-2032)
- 4.3.3 Global Hypnotics and Sedatives Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hypnotics and Sedatives by Application
- 5.1 Hypnotics and Sedatives Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.2 Global Hypnotics and Sedatives Market Size by Application
- 5.2.1 Global Hypnotics and Sedatives Market Size Overview by Application (2021-2032)
- 5.2.2 Global Hypnotics and Sedatives Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Hypnotics and Sedatives Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Hypnotics and Sedatives Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Hypnotics and Sedatives Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Hypnotics and Sedatives Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Hypnotics and Sedatives Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Hypnotics and Sedatives Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Abbott
- 6.1.1 Abbott Company Information
- 6.1.2 Abbott Business Overview
- 6.1.3 Abbott Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Abbott Hypnotics and Sedatives Product Portfolio
- 6.1.5 Abbott Recent Developments
- 6.2 Takeda
- 6.2.1 Takeda Company Information
- 6.2.2 Takeda Business Overview
- 6.2.3 Takeda Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Takeda Hypnotics and Sedatives Product Portfolio
- 6.2.5 Takeda Recent Developments
- 6.3 Sanofi
- 6.3.1 Sanofi Company Information
- 6.3.2 Sanofi Business Overview
- 6.3.3 Sanofi Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Sanofi Hypnotics and Sedatives Product Portfolio
- 6.3.5 Sanofi Recent Developments
- 6.4 Novartis
- 6.4.1 Novartis Company Information
- 6.4.2 Novartis Business Overview
- 6.4.3 Novartis Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Novartis Hypnotics and Sedatives Product Portfolio
- 6.4.5 Novartis Recent Developments
- 6.5 Mylan
- 6.5.1 Mylan Company Information
- 6.5.2 Mylan Business Overview
- 6.5.3 Mylan Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Mylan Hypnotics and Sedatives Product Portfolio
- 6.5.5 Mylan Recent Developments
- 6.6 Pfizer
- 6.6.1 Pfizer Company Information
- 6.6.2 Pfizer Business Overview
- 6.6.3 Pfizer Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Pfizer Hypnotics and Sedatives Product Portfolio
- 6.6.5 Pfizer Recent Developments
- 6.7 Fresenius Kabi
- 6.7.1 Fresenius Kabi Company Information
- 6.7.2 Fresenius Kabi Business Overview
- 6.7.3 Fresenius Kabi Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Fresenius Kabi Hypnotics and Sedatives Product Portfolio
- 6.7.5 Fresenius Kabi Recent Developments
- 6.8 Baxter
- 6.8.1 Baxter Company Information
- 6.8.2 Baxter Business Overview
- 6.8.3 Baxter Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Baxter Hypnotics and Sedatives Product Portfolio
- 6.8.5 Baxter Recent Developments
- 6.9 Sands Pharm
- 6.9.1 Sands Pharm Company Information
- 6.9.2 Sands Pharm Business Overview
- 6.9.3 Sands Pharm Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Sands Pharm Hypnotics and Sedatives Product Portfolio
- 6.9.5 Sands Pharm Recent Developments
- 6.10 Hospira
- 6.10.1 Hospira Company Information
- 6.10.2 Hospira Business Overview
- 6.10.3 Hospira Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Hospira Hypnotics and Sedatives Product Portfolio
- 6.10.5 Hospira Recent Developments
- 6.11 Cobalt Laboratories
- 6.11.1 Cobalt Laboratories Company Information
- 6.11.2 Cobalt Laboratories Business Overview
- 6.11.3 Cobalt Laboratories Hypnotics and Sedatives Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Cobalt Laboratories Hypnotics and Sedatives Product Portfolio
- 6.11.5 Cobalt Laboratories Recent Developments
7 North America by Country
- 7.1 North America Hypnotics and Sedatives Sales by Country
- 7.1.1 North America Hypnotics and Sedatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Hypnotics and Sedatives Sales by Country (2021-2026)
- 7.1.3 North America Hypnotics and Sedatives Sales Forecast by Country (2027-2032)
- 7.2 North America Hypnotics and Sedatives Market Size by Country
- 7.2.1 North America Hypnotics and Sedatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Hypnotics and Sedatives Market Size by Country (2021-2026)
- 7.2.3 North America Hypnotics and Sedatives Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Hypnotics and Sedatives Sales by Country
- 8.1.1 Europe Hypnotics and Sedatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Hypnotics and Sedatives Sales by Country (2021-2026)
- 8.1.3 Europe Hypnotics and Sedatives Sales Forecast by Country (2027-2032)
- 8.2 Europe Hypnotics and Sedatives Market Size by Country
- 8.2.1 Europe Hypnotics and Sedatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Hypnotics and Sedatives Market Size by Country (2021-2026)
- 8.2.3 Europe Hypnotics and Sedatives Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Hypnotics and Sedatives Sales by Country
- 9.1.1 Asia-Pacific Hypnotics and Sedatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Hypnotics and Sedatives Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Hypnotics and Sedatives Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Hypnotics and Sedatives Market Size by Country
- 9.2.1 Asia-Pacific Hypnotics and Sedatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Hypnotics and Sedatives Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Hypnotics and Sedatives Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Hypnotics and Sedatives Sales by Country
- 10.1.1 South America Hypnotics and Sedatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Hypnotics and Sedatives Sales by Country (2021-2026)
- 10.1.3 South America Hypnotics and Sedatives Sales Forecast by Country (2027-2032)
- 10.2 South America Hypnotics and Sedatives Market Size by Country
- 10.2.1 South America Hypnotics and Sedatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Hypnotics and Sedatives Market Size by Country (2021-2026)
- 10.2.3 South America Hypnotics and Sedatives Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Hypnotics and Sedatives Sales by Country
- 11.1.1 Middle East and Africa Hypnotics and Sedatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Hypnotics and Sedatives Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Hypnotics and Sedatives Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Hypnotics and Sedatives Market Size by Country
- 11.2.1 Middle East and Africa Hypnotics and Sedatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Hypnotics and Sedatives Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Hypnotics and Sedatives Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Hypnotics and Sedatives Value Chain Analysis
- 12.1.1 Hypnotics and Sedatives Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Hypnotics and Sedatives Production Mode & Process
- 12.2 Hypnotics and Sedatives Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Hypnotics and Sedatives Distributors
- 12.2.3 Hypnotics and Sedatives Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst